BridgeBio Pharma Inc (BBIO)
26.50
+0.28
(+1.09%)
USD |
NASDAQ |
Dec 20, 16:00
26.49
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Market Cap: 5.007B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc | 149.38B |
| Alnylam Pharmaceuticals Inc | 31.66B |
| Cassava Sciences Inc | 113.54M |
| Regeneron Pharmaceuticals Inc | 77.13B |
| Vertex Pharmaceuticals Inc | 102.31B |
Market Cap Related Metrics
| PS Ratio | 22.18 |
| Price | 26.50 |
| Earnings Yield | -9.10% |